Novel insights into immunology-driven nanomaterials for immunomodulatory bone regeneration: from basics to biological functions

Read full text
Authors: C. Grolle, R.D.K. Misra, Tapash R. Rautray
Cited by: 3
References: 158

Abstract

Nanomaterials are gaining prominence in regenerative medicine because their nanoscale features enable precise drug delivery, cellular regulation and targeted tissue repair. A particularly exciting opportunity lies in their application to immunomodulatory bone regeneration, where nanoscience and immunology intersect to address persistent challenges in bone healing. The recent progress in nanoparticle (NP) design, fabrication and characterization, with emphasis on their dual role as therapeutic carriers and modulators of immune responses, has been highlighted in this study. Both top-down and bottom-up synthesis strategies are discussed, illustrating how particle size, morphology and surface chemistry influence cell-nanosystem interactions. The immune system's responses to nanomaterials are explored in some detail, from beneficial adaptive memory formation to adverse inflammatory reactions, underscoring the delicate balance between efficacy and safety. Limitations of conventional NP systems include cytotoxicity, instability and regulatory hurdles, are examined in conjunction with advanced characterization techniques that relate material properties to biological outcomes. By integrating fundamental nanoscience with immunological perspectives, these fundamental insights into the rational design of nanomaterials for bone regeneration are discussed. The ultimate objective is to provide guidelines for developing safer, more effective strategies that can translate into meaningful clinical applications.

Fields of Study & Subjects

Bone Tissue Engineering Materials Graphene and Nanomaterials Applications Nanoplatforms for cancer theranostics

Publication details

Journal / source
Artificial Cells Nanomedicine and Biotechnology
Publisher
Informa UK Limited
Volume
54
Issue
1
Pages
152–179
Publication date
28 May 2026
Language
EN